Leah Kuntz

Psychiatric Times, your go-to source for what is relevant and important in the field, is pleased to share the following highlights from the 2021 Neuroscience Education Institute Congress.

Individuals with ADHD are 4 times more likely to have generalized anxiety disorder at some point in their life.

The Chief Medical Officer for the American Foundation for Suicide Prevention sat down to talk with Psychiatric Times about the new data on suicide deaths between 2019 and 2020.

Two transgender women in North Carolina are facing struggles in getting prisons to acknowledge their gender identity. What does this say about care for incarcerated transgender individuals in general?

Negative symptoms of schizophrenia are associated with higher overall morbidity and decreased functioning. These study results offer hope.

A coalition of 240 organizations came together to urge Congress to pass legislation to fight the opioid crisis.

The American Academy of Neurology issued a position statement for mental health professionals, warning them to carefully discuss the benefits and known harms of aducanumab.

Cranberry sauce and clinical pearls: the most delicious of combos. Check out more of our November issue.

Need a recap of the custom Around the Practice video program on bipolar disorder? We've got you covered.

A new study examined the relationship between ADHD and oppositional defiant and conduct disorder, callous-unemotional traits, and reward-related inhibitory control.

Treatment-resistant depression: how to diagnose, what treatment options are available, and how to best help patients.

The FDA has approved Dyanavel XR, extended release once-daily tablets for the treatment of attention-deficit/hyperactivity disorder.

How can you provide affirmative mental health care for transgender and gender diverse patients?

Benzodiazepines: a class of medications that evokes that a visceral reaction.

Here’s how to integrate treatment strategies that address both ADHD and comorbid conditions.

Did you miss the Annual Psychiatric Times World CME Conference? Don't worry, we've got you covered.

Can mindfulness be an additional therapy to help treat ADHD in children?

Three leading groups in child and adolescent mental health have declared a state of emergency for the nation’s youth.

One man shares his suicide survival story, and what he does to aid suicide prevention.

Nearly 80% of eating disorders go undetected. What screening tools can help identify them?

PH94B for the treatment of social anxiety disorder further differentiates its mechanism of action from benzodiazepines in a new lab rat preclinical study.

Cultural differences between patients and physician are hard to avoid. How can you best work with diverse patients?

Transgender youth are at increased risk for a number of psychiatric morbidities. Gender identity conversion therapy can make them worse.

Phase 3 results on MDMA-assisted therapy look promising for the treatment of PTSD. What other disorders can psychedelics help treat?

Chronic adolescent exposure to THC and cannabis could lead to adverse mental health outcomes and impacted brain functioning.

Bringing science to the practice of psychiatry has been the personal goal of Sheldon H. Preskorn, MD—the Educator of the Year.

Psychiatric Times' Editor in Chief shared some insights and data on the psychiatric impacts of COVID-19, and what we might expect in the future.

Modifications to the Clozapine Risk Evaluation and Mitigation Strategy go into effect November 15, 2021. Are you up to date?

Caplyta shows promise as a monotherapy for patients with bipolar I or bipolar II disorder experiencing a major depressive episode

The Chief Medical Officer for the American Foundation for Suicide Prevention sat down to talk with Psychiatric Times about a number of important topics in suicide.